A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

NCT06145399 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No accruals

Conditions

Breast Cancer
Breast Carcinoma
Metastatic Breast Cancer
Metastatic Breast Carcinoma
Female Breast Cancer

Interventions

DIAGNOSTIC_TEST: 18F-FDG PET/CT
DIAGNOSTIC_TEST: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone PET Imaging
DRUG: 18F-FDHT

Sponsor

Memorial Sloan Kettering Cancer Center